Cargando…

Monthly Continuous Erythropoietin Receptor Activator Versus Weekly Epoetin-Beta, Similar Hemoglobinization but Different Anisocytosis Degree in Hemodialysis Patients: A Randomized Controlled Trial

BACKGROUND: The monthly continuous erythropoietin receptor activator (CERA) utilization maintains stable hemoglobin (Hb) after conversion from weekly epoetin-β (EB); however, how the different pharmacologic properties affect the red blood cell (RBC) size determined by RBC distribution width (RDW) ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Uriol-Rivera, Miguel G., Obrador-Mulet, Aina, Jimenez-Mendoza, Sonia, Corral-Baez, Antonio, Perianez-Parraga, Leonor, Garcia-Alvarez, Angel, de la Prada, Francisco J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elmer Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8734489/ https://www.ncbi.nlm.nih.gov/pubmed/35059087 http://dx.doi.org/10.14740/jh862

Ejemplares similares

Switch from epoetin to darbepoetin alfa in hemodialysis: dose equivalence and hemoglobin stability
por: Arrieta, Javier, et al.
Publicado: (2014)

The Relation of Erythropoietin Towards Hemoglobin and Hematocrit in Varying Degrees of Renal Insufficiency
por: Panjeta, Mirsad, et al.
Publicado: (2015)

The cost-utility of treating anemia with continuous erythropoietin receptor activator or Epoetin versus routine blood transfusions among chronic hemodialysis patients
por: Maoujoud, Omar, et al.
Publicado: (2016)

Gender Differences in Dose of Erythropoietin to Maintain Hemoglobin Target in Hemodialysis Patients
por: Coronado Daza, J. A., et al.
Publicado: (2019)

Association of Anisocytosis with Markers of Immune Activation and Exhaustion in Treated HIV
por: Al-Kindi, Sadeer G., et al.
Publicado: (2017)

Monocyte anisocytosis corresponds with increasing severity of COVID-19 in children
por: Kane, Abigail S., et al.
Publicado: (2023)

Comparison of Hemoglobin Levels Before and After Hemodialysis and Their Effects on Erythropoietin Dosing and Cost
por: Sagheb, Mohammad Mahdi, et al.
Publicado: (2016)

Effects of the route of erythropoietin administration on hemoglobin variability and cardiovascular events in hemodialysis patients
por: Kim, Do Hyoung, et al.
Publicado: (2021)

ACE gene polymorphism and its association with serum erythropoietin and hemoglobin ‎in Iraqi hemodialysis patients
por: Al-Radeef, Mohanad Yasir, et al.
Publicado: (2019)

Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
por: Yonker, Lael M., et al.
Publicado: (2022)

Comparison of methodologies to define hemodialysis patients hyporesponsive to epoetin and impact on counts and characteristics
por: Gilbertson, David T, et al.
Publicado: (2013)

Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients
por: Beiraghdar, Fatemeh, et al.
Publicado: (2015)

Correction to: Monocyte anisocytosis increases during multisystem inflammatory syndrome in children with cardiovascular complications
por: Yonker, Lael M., et al.
Publicado: (2022)

Differential association of cerebral blood flow and anisocytosis in APOE ε4 carriers at midlife
por: Dounavi, Maria-Eleni, et al.
Publicado: (2023)

Epoetin alfa resistance in hemodialysis patients with chronic kidney disease: a longitudinal study
por: Santos, E.J.F., et al.
Publicado: (2018)

TSAT is a better predictor than ferritin of hemoglobin response to Epoetin alfa in US dialysis patients
por: Gaweda, Adam E, et al.
Publicado: (2014)

Efficacy and safety of subcutaneous administration of lyophilized powder of alfa-erythropoietin to maintain hemoglobin concentrations among hemodialysis patients
por: Satirapoj, Bancha, et al.
Publicado: (2017)

Red blood cell distribution width: A marker of anisocytosis potentially associated with atrial fibrillation
por: Lippi, Giuseppe, et al.
Publicado: (2019)

Economic Benefits of Switching From Intravenous to Subcutaneous Epoetin Alfa for the Management of Anemia in Hemodialysis Patients
por: Prasad, Bhanu, et al.
Publicado: (2020)

Does Erythropoietin Cause Hemoglobin Variability- Is It ‘Normal’?
por: Gupta, Ashwani K, et al.
Publicado: (2014)

Hemoglobin and Erythropoietin After Commercial Saturation Diving
por: Kiboub, Fatima Z., et al.
Publicado: (2018)

Epoetin β pegol (continuous erythropoietin receptor activator, CERA) is another choice for the treatment of anemia in myelodysplastic syndrome: a case report
por: Ikenoue, Tatsuyoshi, et al.
Publicado: (2017)

Efficacy of once or twice weekly administration of epoetin κ in patients receiving hemodialysis: A retrospective study
por: OHTA, SHOICHIRO, et al.
Publicado: (2014)

Effect of occasional epoetin use in combination with a stable darbepoetin dosage on anemia management in hemodialysis patients
por: Shimamatsu, Kazumasa
Publicado: (2014)

Costs Associated With Intravenous Darbepoetin Versus Epoetin Therapy in Hemodialysis Patients: A Randomized Controlled Trial
por: Woodland, Andrea L., et al.
Publicado: (2017)

Quality of Original and Biosimilar Epoetin Products
por: Brinks, Vera, et al.
Publicado: (2010)

Anisocytosis is Associated With Short-Term Mortality in COVID-19 and May Reflect Proinflammatory Signature in Uninfected Ambulatory Adults
por: Hornick, Andrew, et al.
Publicado: (2020)

Comparison of visual assessments of anisocytosis in canine blood smears and analyzer-calculated red blood cell distribution width
por: Jensen, Asger L., et al.
Publicado: (2023)

Dose Conversion Ratio in Hemodialysis Patients Switched from Darbepoetin Alfa to PEG-Epoetin Beta: AFFIRM Study
por: Choi, Peter, et al.
Publicado: (2013)

Safety and Efficacy of Methoxy Polyethylene Glycol-epoetin Beta in Anemia Treatment in Patients on Hemodialysis: a Macedonian Experience
por: Kacarska - Fotevska, Isidora Isidora, et al.
Publicado: (2020)

The Cost-Effectiveness of Using Epoetin-Beta Versus Darbepoetin-Alfa for the Treatment of Anemia Among Chronic Hemodialysis Patients
por: AlKharboush, Hanan, et al.
Publicado: (2020)

Randomized Controlled Trial of Subcutaneous Epoetin Alfa-epbx Versus Epoetin Alfa in End-Stage Kidney Disease
por: Fishbane, Steven, et al.
Publicado: (2019)

Cardiovascular effects of hemoglobin response in patients receiving epoetin alfa and oral iron in heart failure with a preserved ejection fraction
por: Vullaganti, Sirish, et al.
Publicado: (2014)

Epoetin Alpha and Epoetin Zeta: A Comparative Study on Stimulation of Angiogenesis and Wound Repair in an Experimental Model of Burn Injury
por: Irrera, Natasha, et al.
Publicado: (2015)

The Use of Epoetin-α in Revision Knee Arthroplasty
por: Delasotta, Lawrence A., et al.
Publicado: (2012)

Erythropoietin-producing tubercle granuloma in a hemodialysis patient
por: Satoh, Minoru, et al.
Publicado: (2013)

Obesity may be erythropoietin dose-saving in hemodialysis patients
por: El-Kannishy, Ghada M., et al.
Publicado: (2018)

Erythropoietin treatment and the risk of hip fractures in hemodialysis patients
por: Suresh, Sukanya, et al.
Publicado: (2021)

An Interplay between Oxidative Stress (Lactate Dehydrogenase) and Inflammation (Anisocytosis) Mediates COVID-19 Severity Defined by Routine Clinical Markers
por: Alonso-Bernáldez, Marta, et al.
Publicado: (2023)

Toward confirmation of the safety and efficacy of methoxy polyethylene glycol-epoetin beta in anemia treatment in patients on hemodialysis: a Macedonian experience
por: Kacarska-Fotevska, Isidora, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_dlhg48g0na31poo453pihbh6p9